Yabao Pharma Acquires China Rights to Albumin Product from LFB Bio of France

Yabao Pharma formed a partnership with  LFB Biomedicaments, a state-owned French company to bring LFB's albumin product Vialebex ® to China. Yabao will have an exclusive right to register Vialebex with the CFDA and commercialize the product, while LFB will supply product to Yabao. The companies pointed out that China is the world's biggest market for albumin. The terms of the agreement were not disclosed. More details.... Stock Symbol: (SHA: 600351) Share this with colleagues: // //